Search Results - "Guan, Youyan"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Urologic cancer in China by Pang, Cheng, Guan, Youyan, Li, Hongbo, Chen, Wanqing, Zhu, Gang

    Published in Japanese journal of clinical oncology (01-06-2016)
    “…Cancer remains to be the second most common cause of death, and its incidence and mortality rates are increasing in China. According to the 2015 National…”
    Get full text
    Journal Article
  2. 2

    Research Advances in Nucleic Acid Delivery System for Rheumatoid Arthritis Therapy by Zhang, Xintong, Liu, Yanhong, Xiao, Congcong, Guan, Youyan, Gao, Zhonggao, Huang, Wei

    Published in Pharmaceutics (01-04-2023)
    “…Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that affects the lives of nearly 1% of the total population worldwide. With the…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Development and Evaluation of a PSMA-Targeted Nanosystem Co-Packaging Docetaxel and Androgen Receptor siRNA for Castration-Resistant Prostate Cancer Treatment by Zhang, Yingying, Duan, Hongxia, Zhao, Heming, Qi, Lingling, Liu, Yanhong, Zhang, Zheao, Liu, Chao, Chen, Liqing, Jin, Mingji, Guan, Youyan, Gao, Zhonggao, Huang, Wei

    Published in Pharmaceutics (29-04-2022)
    “…Primary prostate cancer (PC) progresses to castration-resistant PC (CRPC) during androgen deprivation therapy (ADR) in early stages of prostate cancer. Thus,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Deaths and adverse events from adjuvant therapy with immune checkpoint inhibitors in solid malignant tumors: A systematic review and network meta‐analysis by Xie, Ruiyang, Wu, Jie, Shang, Bingqing, Bi, Xingang, Cao, Chuanzhen, Guan, Youyan, Shi, Hongzhe, Shou, Jianzhong

    Published in Cancer innovation (Print) (01-12-2022)
    “…Background By prolonging overall survival and reducing disease recurrence rates, immune checkpoint inhibitors (ICIs) are an emerging adjuvant therapy option…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol by Meng, Lingwei, Chu, Xiaoyang, Xing, Haoyue, Liu, Xuan, Xin, Xin, Chen, Liqing, Jin, Mingji, Guan, Youyan, Huang, Wei, Gao, Zhonggao

    Published in International journal of pharmaceutics (15-08-2019)
    “…Borneol (BO) was firstly conjugated with DSPE-PEG2000-COOH to synthesize a novel carrier DSPE-PEG2000-BO to enhance the delivery of doxorubicin (DOX) into…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Enhancing anti-melanoma outcomes in mice using novel chitooligosaccharide nanoparticles loaded with therapeutic survivin-targeted siRNA by Liu, Xuan, Chen, Liqing, Zhang, Yingying, Xin, Xin, Qi, Lingling, Jin, Mingji, Guan, Youyan, Gao, Zhonggao, Huang, Wei

    “…Melanoma anti-tumor therapy remains a challenge. SiRNA-based therapies provide a powerful means, but limitations remain in its pharmaceutical applications…”
    Get full text
    Journal Article
  12. 12

    Serum IgG: A potential biomarker for predicting the efficacy of systemic therapy in metastatic renal cell carcinoma by Cui, Honglei, Wu, Jie, Xie, Rui-Yang, Du, Gan, Shang, Bing-Qing, Dong, Xin, Song, Yan, Qu, Wang, Bai, Hongsong, Guan, Youyan, Shi, Hongzhe, Bi, Xin-Gang, Zhou, Ai-Ping, Shou, Jianzhong

    Published in Journal of clinical oncology (01-02-2024)
    “…442 Background: Immunotherapy-tyrosine kinase inhibitor (IO-TKI) and tyrosine kinase inhibitor (TKI) are the main treatment strategies that have significantly…”
    Get full text
    Journal Article
  13. 13

    Neoadjuvant combined chemotherapy and immunotherapy for upper tract urothelial carcinoma: Preliminary results from a phase II study by Bi, Xin-Gang, Zhang, Wen, Xie, Yaoyu, Wu, Jie, Cui, Honglei, Cao, Chuanzhen, Lu, Li, Wen, Li, Guan, Youyan, Shi, Hongzhe, Xiao, Zhendong, Jiang, Zhichao, Sun, Yongkun, Zheng, Shan, Zhang, Jin, Zhou, Aiping, Shou, Jianzhong

    Published in Journal of clinical oncology (01-02-2024)
    “…636 Background: Upper Tract Urothelial Carcinoma (UTUC) presents a challenging prognosis even after Radical Nephroureterectomy (RNU), and postoperative renal…”
    Get full text
    Journal Article
  14. 14

    Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma by Xie, Ruiyang, Wu, Jie, Shang, Bingqing, Cao, Chuanzhen, Bi, Xingang, Shi, Hongzhe, Shou, Jianzhong, Guan, Youyan

    Published in Journal of oncology (30-06-2022)
    “…Background. The transmembrane transporter Sema3D is a vital molecule involved in axon guidance and carcinogenesis of variant malignancies. However, the…”
    Get full text
    Journal Article
  15. 15

    Abstract 2296: A multicenter, prospective evaluation of urine-based ctDNA assay for urinary cancers diagnosis by Qu, Hu, Zeng, Yu, Li, Yan, Guan, Youyan, Liu, Jianhe, Zheng, Kewen, Lyu, Jia, Zhang, Xiaoyan, Li, Le, Feng, Jiao, Liang, Yiming, Ma, Tonghui

    Published in Cancer research (Chicago, Ill.) (15-08-2020)
    “…Abstract Background: There is still some limitations for the diagnosis of urinary cancers, such as the invasiveness of cystoscopy and ureteroscopy, the…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Reninoma coexisting with adrenal adenoma during pregnancy: A case report by Xue, Mei, Chen, Yan, Zhang, Jin, Guan, Youyan, Yang, Lin, Wu, Bing

    Published in Oncology letters (01-05-2017)
    “…Reninoma is a rare form of secondary hypertension. The present study reported a case of reninoma that coexisted with an adrenal adenoma in a young female with…”
    Get full text
    Journal Article